10x Genomics’ (TXG) Sell (E+) Rating Reiterated at Weiss Ratings
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of other research analysts have also recently commented on the company. UBS Group decreased their price target on 10x Genomics from $20.00 to […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of other research analysts have also recently commented on the company. UBS Group decreased their price target on 10x Genomics from $20.00 to […]
